Patheon

Patheon Inc. is a provider of comprehensive pharmaceutical development and manufacturing services tailored for the pharmaceutical and biotechnology sectors worldwide. Established in 1974 and headquartered in Mississauga, Canada, the company specializes in the manufacture of prescription and over-the-counter products across various dosage forms, including solid, semi-solid, liquid, and sterile formats. Patheon's service offerings encompass the entire lifecycle of pharmaceutical products, beginning with early development and continuing through to commercial manufacturing. These services include specialized capabilities in high-potency compounds, sterile production, lyophilization, and controlled-release formulations, as well as logistics and packaging solutions. Additionally, Patheon aids clients in the drug approval process by providing contract development services, which involve pre-formulation, analytical method development, and the manufacture of pilot batches, alongside clinical packaging and technology transfer services to support commercial-scale operations. The company operates globally, delivering products to approximately 120 countries.